Literature DB >> 7952619

Impairment of cerebral perfusion during obstructive sleep apneas.

E M Bålfors1, K A Franklin.   

Abstract

Cerebral circulation was studied in six patients with obstructive sleep apnea (OSA) by transcranial Doppler. Cerebral blood flow velocity (CBFV), pulsatility index (Pi), intra-arterial radial blood pressure, transcutaneous blood gases, and respiration were recorded during sleep with or without apneas. There was a concomitant increase of mean arterial pressure (Pa) and CBFV by 11 +/- 6% (p < 0.001) and 15 +/- 6% (p < 0.001) compared with baseline at 5.1 +/- 2.4 and 5.3 +/- 2.6 s, respectively, after apnea termination. Pa and CBFV decreased to a minimum of -8 +/- 2% (p < 0.001) and -23 +/- 8% (p < 0.001), respectively, below baseline at 19.8 +/- 5.0 and 19.4 +/- 4.5 s after apnea. Values returned to baseline within 60 s, except during repetitive apneas, which were associated with prolonged periods of reduced Pa and CBFV. Pi changed inversely to CBFV and rose to 34 +/- 15% (p < 0.001) above baseline 19.5 +/- 5.5 s after the end of apnea because of a decrease in diastolic CBFV. There was a close correlation between Pa and CBFV (r = 0.67, p < 0.001), indicating that cerebral autoregulation is insufficient to protect the brain from rapid systemic pressure changes in OSA. The findings suggest that apneas during sleep are associated with profound changes in cerebral blood flow. Apnea-induced hypoxemia combined with reduced cerebral perfusion may predispose to nocturnal cerebral ischemia in patients with OSA.

Entities:  

Mesh:

Year:  1994        PMID: 7952619     DOI: 10.1164/ajrccm.150.6.7952619

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  57 in total

Review 1.  Morbidity of obstructive sleep apnea in children: facts and theory.

Authors:  D Gozal
Journal:  Sleep Breath       Date:  2001       Impact factor: 2.816

2.  Mortality in Obstructive Sleep Apnea: Association with Impaired Wakefulness.

Authors:  J. Steven Poceta; Daniel I. Loube; Erin L. Kellgren; Kaysha Bizik; Merrill M. Mitler
Journal:  Sleep Breath       Date:  1999       Impact factor: 2.816

3.  [Ocular risks in obstructive sleep apnea syndrome].

Authors:  A Steindel; C Lautenschläger; H G Struck
Journal:  Ophthalmologe       Date:  2010-11       Impact factor: 1.059

4.  The effect of simulated obstructive apnoea on intraocular pressure and pulsatile ocular blood flow in healthy young adults.

Authors:  P O Lundmark; G E Trope; J G Flanagan
Journal:  Br J Ophthalmol       Date:  2003-11       Impact factor: 4.638

5.  Stroke and sleep specialists: an opportunity to intervene?

Authors:  Nathaniel F Watson
Journal:  J Clin Sleep Med       Date:  2010-04-15       Impact factor: 4.062

6.  Changes in cerebral hemoglobin indices in obstructive sleep apnea syndrome with nasal continuous positive airway pressure treatment.

Authors:  Akira Matsuo; Yuichi Inoue; Kazuyoshi Namba; Hiroshige Chiba
Journal:  Sleep Breath       Date:  2010-06-30       Impact factor: 2.816

7.  Cerebrovascular pulsatility in patients with sleep-disordered breathing.

Authors:  Alberto R Ramos; Digna Cabral; David J Lee; Ralph L Sacco; Tatjana Rundek
Journal:  Sleep Breath       Date:  2012-07-07       Impact factor: 2.816

8.  Manganese superoxide dismutase protects mouse cortical neurons from chronic intermittent hypoxia-mediated oxidative damage.

Authors:  Xiaoyang Shan; Liying Chi; Yan Ke; Chun Luo; Steven Qian; David Gozal; Rugao Liu
Journal:  Neurobiol Dis       Date:  2007-07-21       Impact factor: 5.996

Review 9.  "Boomerang Neuropathology" of Late-Onset Alzheimer's Disease is Shrouded in Harmful "BDDS": Breathing, Diet, Drinking, and Sleep During Aging.

Authors:  Mak Adam Daulatzai
Journal:  Neurotox Res       Date:  2015-04-25       Impact factor: 3.911

10.  Acceleration of cerebral blood flow velocity in a patient with sleep apnea and intracranial arterial stenosis.

Authors:  Stephan Behrens; Konstantinos Spengos; Michael Hennerici
Journal:  Sleep Breath       Date:  2002-09       Impact factor: 2.816

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.